HOXD10 acts as a tumor-suppressive factor via inhibition of the RHOC/AKT/MAPK pathway in human cholangiocellular carcinoma

HOXD10, a key regulator of cell-differentiated phenotype maintainence, has been demonstrated to be involved in the tumorigenesis of many human malignacies. However, the status of HOXD10 expression and its biological function in cholangiocellular carcinoma (CCC) remain to be clarified. In the present...

Descripción completa

Detalles Bibliográficos
Autores principales: YANG, HAIXIA, ZHOU, JIUPENG, MI, JIANQIANG, MA, KE, FAN, YANGWEI, NING, JING, WANG, CHUYING, WEI, XIN, ZHAO, HUADONG, LI, ENXIAO
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4564083/
https://www.ncbi.nlm.nih.gov/pubmed/26260613
http://dx.doi.org/10.3892/or.2015.4194

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4564083/
https://www.ncbi.nlm.nih.gov/pubmed/26260613
http://dx.doi.org/10.3892/or.2015.4194

Ejemplares similares